pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vykat XR · news · pharmadog
← back to Vykat XR
News mentioning Vykat XR
10
stories
15d
Neurocrine defends Prader-Willi drug after another patient death
biospace
26d
FDA uncages Aardvark’s Prader-Willi study after new data cleared safety concerns
biospace
Oct 13, 26
STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
stat
Oct 13, 26
STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
stat
Sep 3, 26
An AI drug specialist zeroes in on rare forms of obesity
biopharma dive
Aug 12, 26
Four questions on new safety warnings for Neurocrine’s Vykat XR
endpoints
Aug 12, 26
Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug
biospace
Aug 12, 26
STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more
stat
Aug 12, 26
STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
stat
Aug 3, 26
Novo’s late-stage IL-6 stumble shakes inflammation space
biospace